Iceland vs Sri Lanka: 10_Insured export credit exposures, short term
Iceland
1.25 billion BU
in 2025
Sri Lanka
1.24 billion BU
in 2025
Iceland rank
96th
Sri Lanka rank
97th
10_Insured export credit exposures, short term over time
- Iceland
- Sri Lanka
How they compare
Iceland currently reports 1.25 billion BU against 1.24 billion BU in Sri Lanka, a difference of 8.00 million BU.
The two have swapped places 2 times across 21 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 96th and Sri Lanka ranks 97th of 210 countries.
Across the 3 decades both report, Iceland averaged higher in 1 and Sri Lanka in 2.
Head to head by decade
| Decade | Iceland | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 490.80 million BU | 364.40 million BU | 126.40 million BU | Iceland |
| 2010s | 378.90 million BU | 852.40 million BU | 473.50 million BU | Sri Lanka |
| 2020s | 1.09 billion BU | 1.53 billion BU | 443.17 million BU | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Iceland or Sri Lanka?
- Iceland, at 1.25 billion BU against 1.24 billion BU in Sri Lanka as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Iceland and Sri Lanka?
- 8.00 million BU, with Iceland ahead.
- How many years of comparable data are there for Iceland and Sri Lanka?
- 21 years are reported by both, from 2005 to 2025.
- How do Iceland and Sri Lanka rank globally for 10_insured export credit exposures, short term?
- Iceland ranks 96th and Sri Lanka ranks 97th of 210 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).